How an LP Should Read a Continuation Vehicle Fairness Opinion Before Deciding to Roll or Sell

TL;DR: Continuation vehicles generated $65 billion of GP-led secondary volume in the first half of 2026, up 35% year over year, according to Evercore's H1 2026 Secondary Market Review — and every one of those transactions handed existing LPs a fairness opinion, a tight election deadline, and a roll-or-sell decision most were not fully equipped to evaluate. This checklist changes that.

The Structural Conflict That Makes the Opinion Matter

A continuation vehicle (CV) is a GP-led secondary transaction where the fund manager moves one or more portfolio assets from an aging fund into a new vehicle it also controls. Existing LPs in the selling fund get a choice: roll their interest into the new vehicle and keep exposure to the asset, or take cash at the tender price offered by incoming buyers.

The conflict is fundamental. As manager of the selling fund, the GP has a fiduciary obligation to maximize what LPs receive. As manager of the new continuation vehicle, the GP has a competing interest in acquiring that same asset at the lowest defensible price to generate stronger returns for incoming investors and a fresh carried interest clock for itself. A single party sits on both sides of the trade.

A fairness opinion from an independent investment bank or valuation firm is the primary external check on whether the price reflects fair value. ILPA's 2023 continuation funds guidance notes that such an opinion is particularly important because "the NAV is determined by the GP, and typically a trailing NAV will be used as a reference point in setting price." The same party that controls the book value of the asset also controls the benchmark against which fairness gets measured.

The SEC agreed this structure warranted a regulatory response. In August 2023, it adopted the Private Fund Adviser Rules requiring registered advisers conducting GP-led secondary transactions to obtain a fairness or valuation opinion from an independent provider and distribute it to all existing fund investors. The Fifth Circuit vacated those rules in 2024. The mandate no longer applies, but Willkie's 2025 analysis of SEC examination risk in GP-led secondaries confirms that conflicts in these transactions remain an active regulatory focus. The fairness opinion survives as the industry's standard voluntary mechanism for addressing the pricing conflict, which is exactly why LPs need to know how to read one critically.

The Six-Point Fairness Opinion Checklist

Work through each point before submitting your election form. The questions below draw on ILPA's guidance, SEC commentary, and the structural features of how these transactions are actually run.

1. Who issued the opinion, and what is their relationship with the GP?

   Start with the cover page. The opinion provider should be a nationally recognized investment bank or established valuation firm with no meaningful economic relationship with the GP outside this specific engagement. Ask three specific questions:

   • Has this firm advised the GP or any of its affiliates on fund formation, capital placement, or portfolio company transactions in the previous 24 months? ILPA's guidance states the GP "should disclose any potential conflicts of interest with the advisor and the commercial arrangement." If that disclosure is absent, request it in writing before you elect.
   • Is the fee contingent on the transaction closing? A success-based fee gives the opinion provider a direct financial incentive to conclude the price is fair. A fixed retainer does not.
   • Has this same firm issued fairness opinions for other GP-led transactions organized by the same sponsor? Repeat engagement can undermine independence even when individual engagements look clean on paper.

   ILPA also specifies that the LP Advisory Committee (LPAC) has "the right to avail itself of an experienced independent legal and specialist advisor, separate from the GP-selected advisor." If the LPAC retained its own advisor, find out what that review concluded. It is not always disclosed in the LP package without a specific request.

2. What valuation methodology did the provider use, and does it match market practice for this asset type?

   Read the methodology section, not just the conclusion. A typical fairness opinion relies on one or more of the following: discounted cash flow (DCF) analysis, comparable public company multiples, precedent M&A transaction multiples, and prior pricing on similar CVs in the secondary market. Each carries assumptions the GP influences or controls.

   For a DCF, the GP typically supplies the financial projections. Those projections are management estimates, not independently audited figures. Check whether the opinion provider applied sensitivity analysis to the base case, what discount rate was selected, and whether the terminal value assumption reflects where buyers have actually cleared comparable assets in the secondaries market.

For comparable transactions, verify that the comps are genuinely comparable. A software company trading at 15x EBITDA is not a useful benchmark for a healthcare services business at 8x. Check sector alignment, growth profile, and vintage. An opinion built on a thin or mismatched comparable set can arrive at almost any conclusion the methodology permits.

What data did the GP provide to the opinion firm, and was any of it independently verified?

This is the hardest point to assess from outside the process and may be the most important one. The opinion provider can conclude only that the price is fair relative to the information it received. If the GP supplied optimistic projections, excluded downside scenarios, or withheld material risk factors, the resulting opinion can be technically defensible while resting on a flawed foundation.

ILPA's 2023 guidance calls for the GP to provide LPs with "GP's diligence on material risks of the assets, details on valuations and modeling assumptions used," and the GP's own view on exit plans and potential returns. If your documents do not include at least a summary of that underlying information, request it from the LPAC or directly from the GP before your election deadline.

How does the tender price compare to the fund's last reported NAV and to any recent arm's-length transactions in the same asset?

The tender price is the cash value offered to LPs who elect to exit. Check it against two benchmarks.

First, compare it to the fund's most recently reported net asset value (NAV) for the asset. According to Lazard's H1 2026 Secondary Market Review, approximately 87% of single-asset continuation fund volume priced above 90% of NAV in H1 2026, with 23% pricing above par. A tender price more than 10 percentage points below the last reported NAV requires a documented explanation: either the NAV is stale and the asset has deteriorated, the competitive process cleared at a discount, or the LP is being asked to accept less than fair value.

Second, look for any recent minority stake sales, co-investment transactions, or secondary market trades in the same portfolio company. These are arm's-length data points the opinion provider should have considered. If a secondary buyer purchased a stake six months ago at an implied valuation 20% above the CV tender price, that gap requires a direct explanation, not a general statement that markets have moved.

What are the GP's economics in the continuation vehicle compared to yours?

The GP receives benefits from a CV that do not flow to rolling LPs. Three areas require specific attention.

New management fees: The CV pays management fees from inception. Whether or not the asset appreciates, the GP collects fee revenue on the new vehicle's committed capital.

New carry clock: In most CVs, carried interest resets to the CV entry valuation. Rolling LPs start their carry clock at the CV price, not at the original cost basis in the predecessor fund. The GP can therefore earn carry on appreciation that existing LPs had already effectively "paid for" through their original investment period.

Crystallization of accrued carry: Where the selling fund is already in carry, the GP may crystallize previously accrued but uncollected carried interest at the time of the CV transaction. ILPA's guidance states that "in almost every case" the GP should roll 100% of accrued carried interest into the CV rather than cash it out, to preserve alignment. When the GP does not roll 100%, it extracts cash from the transaction, reducing what LPs effectively receive. Verify the percentage being rolled and demand the written rationale for any amount below 100%.

The Jefferies H1 2026 Global Secondary Market Review notes that "super carry" (carried interest rates above the standard 20%) appeared in a growing share of GP-led deals in 2026. If the continuation vehicle carries a super carry tier, model what that means for LP returns at different exit scenarios before deciding to roll.

How much time did LPs actually get to decide, and was there a real market check?

Process fairness covers both the timeline and the competitive dynamics that set the price.

On timeline: ILPA recommends that LPs receive at least 10 business days from finalization of transaction terms to their election deadline. Many CVs run three to four calendar weeks from announcement to election close. Count business days from when you had the complete information package, including the fairness opinion itself. A 10-business-day clock that starts before the opinion is distributed is not a real review period.

On market check: Ask whether the process included competitive bidding from multiple lead investors, or whether a single anchor investor set the price with no meaningful competition. Willkie's 2025 SEC examination analysis identifies conducting "a competitive auction process with a price to be set by one or more Lead Investors" as the primary mechanism for cleansing the GP's pricing conflict. A single-investor process with no competing bids is harder to defend as producing a market price, regardless of what the fairness opinion states.

What the Opinion Cannot Tell You

A fairness opinion that clears all six tests above is meaningful evidence that the transaction was run with reasonable care and that the price offered is within a defensible range. It is not a guarantee of fair value, and it cannot answer the questions that matter most for your own portfolio decision.

The opinion is a point-in-time assessment built on information the provider received before signing. Material developments after the opinion date will not be captured: a deteriorating customer, a regulatory shift, or a repricing of comparable assets. It also addresses only one question: whether the cash consideration offered to exiting LPs is fair from a financial point of view. It does not address whether rolling over is the right decision for you specifically, or whether the GP's track record managing this holding justifies continued confidence.

The fairness opinion is one input, not a conclusion. According to the Willamette Management Associates July 2025 analysis of conflict transactions and fairness opinions, a properly executed opinion "can deter or defend against litigation and serves as evidence of proper procedure." What it cannot do is substitute for your own judgment about whether the asset and the GP deserve more of your capital at the price on offer.

Frequently Asked Questions

Does the GP have to provide a fairness opinion at all?

Not currently under federal law. The SEC's August 2023 Private Fund Adviser Rules would have required registered advisers to obtain and distribute independent fairness or valuation opinions for GP-led secondary transactions, but the Fifth Circuit vacated those rules in 2024. ILPA's 2023 guidance recommends opinions as best practice, but compliance is voluntary. You can ask the LPAC whether one was obtained and demand a copy. A refusal to produce it is itself a data point about process quality.

What is the difference between a fairness opinion and a valuation opinion?

A fairness opinion states that the consideration offered is "fair from a financial point of view" to a specified party. A valuation opinion states the provider's estimate of what a security or asset is worth, expressed as a value or range. For LP decision-making, a fairness opinion is more directly useful because it addresses the specific transaction price you are being offered, rather than leaving you to compare an abstract value estimate to the tender price yourself.

Can I split my election between rolling and cashing out?

Often yes. Many CV structures allow LPs to roll a portion of their interest while taking cash for the remainder. A partial election can be useful when you want to maintain some exposure to the asset without committing your full position to a new fee-paying vehicle at a reset carry basis. Check the election form carefully: partial election minimums, rounding conventions, and cutoff thresholds vary by transaction.

What happens if I miss the election deadline?

Default treatment is specified in the offering documents and differs by transaction. Some CVs default non-electing LPs to the cash-out option; others roll non-electors into the continuation vehicle. Missing the deadline when the default is to roll may leave you in a multi-year hold in a vehicle you did not evaluate. Treat the election deadline as a hard cutoff and make a deliberate choice rather than allowing a default to make it for you.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.